LMAT vs. STVN, GKOS, NARI, INSP, IRTC, BLCO, TMDX, SLNO, NVST, and PRCT
Should you be buying LeMaitre Vascular stock or one of its competitors? The main competitors of LeMaitre Vascular include Stevanato Group (STVN), Glaukos (GKOS), Inari Medical (NARI), Inspire Medical Systems (INSP), iRhythm Technologies (IRTC), Bausch + Lomb (BLCO), TransMedics Group (TMDX), Soleno Therapeutics (SLNO), Envista (NVST), and PROCEPT BioRobotics (PRCT). These companies are all part of the "medical equipment" industry.
LeMaitre Vascular vs.
Stevanato Group (NYSE:STVN) and LeMaitre Vascular (NASDAQ:LMAT) are both medical companies, but which is the better business? We will compare the two companies based on the strength of their profitability, earnings, valuation, institutional ownership, dividends, media sentiment, analyst recommendations, risk and community ranking.
LeMaitre Vascular received 484 more outperform votes than Stevanato Group when rated by MarketBeat users. Likewise, 70.45% of users gave LeMaitre Vascular an outperform vote while only 63.27% of users gave Stevanato Group an outperform vote.
Stevanato Group has higher revenue and earnings than LeMaitre Vascular. LeMaitre Vascular is trading at a lower price-to-earnings ratio than Stevanato Group, indicating that it is currently the more affordable of the two stocks.
Stevanato Group has a beta of 0.51, indicating that its share price is 49% less volatile than the S&P 500. Comparatively, LeMaitre Vascular has a beta of 0.86, indicating that its share price is 14% less volatile than the S&P 500.
84.6% of LeMaitre Vascular shares are held by institutional investors. 0.7% of Stevanato Group shares are held by insiders. Comparatively, 9.5% of LeMaitre Vascular shares are held by insiders. Strong institutional ownership is an indication that endowments, hedge funds and large money managers believe a stock will outperform the market over the long term.
LeMaitre Vascular has a net margin of 19.40% compared to Stevanato Group's net margin of 10.47%. LeMaitre Vascular's return on equity of 13.15% beat Stevanato Group's return on equity.
LeMaitre Vascular has a consensus price target of $98.14, suggesting a potential upside of 24.04%. Given LeMaitre Vascular's higher probable upside, analysts plainly believe LeMaitre Vascular is more favorable than Stevanato Group.
In the previous week, LeMaitre Vascular had 1 more articles in the media than Stevanato Group. MarketBeat recorded 8 mentions for LeMaitre Vascular and 7 mentions for Stevanato Group. Stevanato Group's average media sentiment score of 1.74 beat LeMaitre Vascular's score of 0.58 indicating that Stevanato Group is being referred to more favorably in the media.
Stevanato Group pays an annual dividend of €0.06 per share and has a dividend yield of 0.3%. LeMaitre Vascular pays an annual dividend of $0.80 per share and has a dividend yield of 1.0%. Stevanato Group pays out 11.8% of its earnings in the form of a dividend. LeMaitre Vascular pays out 40.4% of its earnings in the form of a dividend. Both companies have healthy payout ratios and should be able to cover their dividend payments with earnings for the next several years. Stevanato Group has increased its dividend for 1 consecutive years and LeMaitre Vascular has increased its dividend for 14 consecutive years. LeMaitre Vascular is clearly the better dividend stock, given its higher yield and longer track record of dividend growth.
Summary
LeMaitre Vascular beats Stevanato Group on 14 of the 21 factors compared between the two stocks.
Get LeMaitre Vascular News Delivered to You Automatically
Sign up to receive the latest news and ratings for LMAT and its competitors with MarketBeat's FREE daily newsletter.
New MarketBeat Followers Over Time
This chart shows the number of new MarketBeat users adding {thisCompany.Symbol} and its top 5 competitors to their watchlist. Each company is represented with a line over a 90 day period.
Skip ChartMedia Sentiment Over Time
This chart shows the average media sentiment of NASDAQ and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.
Skip Chart
LeMaitre Vascular Competitors List
Related Companies and Tools
This page (NASDAQ:LMAT) was last updated on 5/23/2025 by MarketBeat.com Staff